Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;62(3S):S18-S26.
doi: 10.1016/j.jadohealth.2017.09.030.

Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

Affiliations

Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review

Stuart A Kinner et al. J Adolesc Health. 2018 Mar.

Abstract

Purpose: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners.

Methods: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners.

Results: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%-25.2%), hepatitis C (.0%-70.6%), HIV (.0%-15.8%), and active tuberculosis (.0%-3.7%). The pooled prevalence of HIV (RR = .39, 95% confidence interval .29-.53, I2 = 79.2%) and hepatitis C (RR = .51, 95% confidence interval .33-.78, I2 = 97.8%) was lower in AYAs than in older prisoners.

Conclusions: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.

Keywords: Adolescent; HIV; Hepatitis B; Hepatitis C; Injecting drug use; Meta-analysis; Prisoners; Tuberculosis; Young adult.

PubMed Disclaimer

Conflict of interest statement

The study sponsors had no role in study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the manuscript for publication. S.A.K. and K.S. co-authored the first draft of the manuscript. No honorarium, grant, or other form of payment was given to anyone to produce the manuscript.

Figures

Figure 1
Figure 1
HBV in young versus older prisoners (mixed group excluded).
Figure 2
Figure 2
HCV in young versus older prisoners (mixed group excluded).
Figure 3
Figure 3
HIV in young versus older prisoners (mixed group excluded).
Figure 4
Figure 4
TB in young versus older prisoners (mixed group excluded).

Similar articles

Cited by

References

    1. Walmsley R. World prison population list. 11th ed. London: International Centre for Prison Studies, Kings College; 2016.
    1. van Dooren K, Kinner SA, Forsyth S. Risk of death for young ex-prisoners in the year following release from adult prison. Aust N Z J Public Health 2013. 37:377–82. - PubMed
    1. Avery A, Kinner SA. A robust estimate of the number and characteristics of persons released from prison in Australia. Aust N Z J Public Health 2015;39:315–8. - PubMed
    1. Carson EA, Anderson E. Prisoners in 2015 Bulletin. Washington (DC): US Bureau of Justice Statistics; 2016. December 2016. Report No.: NCJ 250229.
    1. AIHW Youth justice in Australia 2014-15. Bulletin. Canberra: Australian Institute of Health and Welfare; 2016 April 2016. Report No.: 133.

Publication types